IRIS Accounts Production v23.3.0.418 07967638 Board of Directors 1.3.22 28.2.23 28.2.23 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh079676382022-02-28079676382023-02-28079676382022-03-012023-02-28079676382021-02-28079676382021-03-012022-02-28079676382022-02-2807967638ns10:Originalns15:EnglandWales2022-03-012023-02-2807967638ns14:PoundSterlingns10:Original2022-03-012023-02-2807967638ns10:Originalns10:Director12022-03-012023-02-2807967638ns10:Original2022-03-012023-02-2807967638ns10:Original2023-02-2807967638ns10:Originalns10:PrivateLimitedCompanyLtd2022-03-012023-02-2807967638ns10:Originalns10:SmallEntities2022-03-012023-02-2807967638ns10:Originalns10:AuditExempt-NoAccountantsReport2022-03-012023-02-2807967638ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-03-012023-02-2807967638ns10:SmallCompaniesRegimeForAccountsns10:Original2022-03-012023-02-2807967638ns10:Originalns10:FullAccounts2022-03-012023-02-2807967638ns10:Originalns10:Director22022-03-012023-02-2807967638ns10:Originalns10:RegisteredOffice2022-03-012023-02-2807967638ns10:Original2022-02-2807967638ns10:Originalns5:CurrentFinancialInstruments2023-02-2807967638ns10:Originalns5:CurrentFinancialInstruments2022-02-2807967638ns5:ShareCapitalns10:Original2023-02-2807967638ns5:ShareCapitalns10:Original2022-02-2807967638ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-02-2807967638ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-02-2807967638ns10:Originalns5:PlantMachinery2022-03-012023-02-2807967638ns10:Original2021-03-012022-02-2807967638ns10:Originalns5:PlantMachinery2022-02-2807967638ns10:Originalns5:PlantMachinery2023-02-2807967638ns10:Originalns5:PlantMachinery2022-02-2807967638ns10:Original2022-02-2807967638ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-02-2807967638ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-02-28
REGISTERED NUMBER: 07967638 (England and Wales)


















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 28 FEBRUARY 2023

FOR

VSS MEDICAL LTD

VSS MEDICAL LTD (REGISTERED NUMBER: 07967638)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


VSS MEDICAL LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 28 FEBRUARY 2023







DIRECTORS: V S Sidhu
J K Sidhu





REGISTERED OFFICE: 34-40 High Street
Wanstead
London
E11 2RJ





REGISTERED NUMBER: 07967638 (England and Wales)





ACCOUNTANTS: THP Limited
Chartered Accountants
Unit 4 Mulgrave Chambers
26-28 Mulgrave Road
Sutton
Surrey
SM2 6LE

VSS MEDICAL LTD (REGISTERED NUMBER: 07967638)

BALANCE SHEET
28 FEBRUARY 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 - -
Investment property 5 605,574 605,574
605,574 605,574

CURRENT ASSETS
Debtors 6 13,462 12,812
Cash at bank 64,711 24,066
78,173 36,878
CREDITORS
Amounts falling due within one year 7 23,838 24,540
NET CURRENT ASSETS 54,335 12,338
TOTAL ASSETS LESS CURRENT
LIABILITIES

659,909

617,912

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 659,809 617,812
SHAREHOLDERS' FUNDS 659,909 617,912

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 1 October 2023 and were signed on its behalf by:





V S Sidhu - Director


VSS MEDICAL LTD (REGISTERED NUMBER: 07967638)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023


1. STATUTORY INFORMATION

VSS Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Going concern
The financial statements are prepared on the going concern basis, which assumes the ability of the company to continue its activities for the foreseeable future, being a period of not less than twelve months from the approval of these accounts.

The directors, having considered all the information available, are confident that the company has adequate reserves and resources to continue its operational activities for the foreseeable future. Accordingly, the directors are satisfied that the going concern basis continues to be appropriate for the preparation of the annual financial statements.

Revenue recognition
Revenue is measured at the fair value of the consideration received or receivable and represents the amount receivable for services supplied, net of returns and discounts.

Revenue is recognised in the accounting period in which the services were rendered.

Revenue in respect of rental income is accounted for on a receiveable basis.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on cost

Investment property
Investment Properties are shown at fair value. Any aggregate surplus or deficit that arises from a change in fair value is recognised in the income statement, net of deferred tax. On an annual basis this surplus or deficit is transferred from retained profits into a separate, non-distributable reserve called the "Revaluation Reserve".

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

VSS MEDICAL LTD (REGISTERED NUMBER: 07967638)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2023


4. TANGIBLE FIXED ASSETS
Plant and
machinery
£   
COST
At 1 March 2022
and 28 February 2023 6,774
DEPRECIATION
At 1 March 2022
and 28 February 2023 6,774
NET BOOK VALUE
At 28 February 2023 -
At 28 February 2022 -

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 March 2022
and 28 February 2023 605,574
NET BOOK VALUE
At 28 February 2023 605,574
At 28 February 2022 605,574

The directors confirm that the property remains fair valued on an open market basis based on all available market data at £605,574 (2022: £605,574) which equates to its original cost.

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 11,256 10,428
Other debtors 300 651
Prepayments 1,906 1,733
13,462 12,812

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Corporation tax 10,770 10,473
Social security and other taxes 39 -
Directors' current accounts 8,843 10,001
Accrued expenses 4,186 4,066
23,838 24,540

8. RELATED PARTY DISCLOSURES

At the year end the directors were owed £8,843 (2022: £10,001) in respect of their current accounts, the current accounts are provided interest free and with no formal terms of repayment.